Growth Hormone Deficiency
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Written informed consent from parents or legal guardian, in the case of a child aged 12 years or older written informed consent from both parents/legal guardian and the child; - Patients must be 0-17 years of age; - Patients must have an indication for a clonidine test to investigate a possible growth hormone deficiency, and this is to be decided by or under supervision of a staff paediatrician, paediatric endocrinologist or fellow
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Pharmacokinetics of clonidine following oral administration - Growth hormone response following oral administration of clonidine - Cortisol response following oral administration of clonidine - Sedation depth following clonidine oral administration, measured with modified Ramsay Sedation Scale - Hemodynamic and respiratory parameters (Blood Pressure, Heart Rate, Transcutaneous oxygen saturation) following oral administration of clonidine | — |
Secondary
| Measure | Time frame |
|---|---|
| - Basal ACTH - Heart rate variability - QTc times before and after clonidine administration. | — |
Countries
Netherlands